205 related articles for article (PubMed ID: 28242662)
1. Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Mazzeti AL; Gonçalves KR; Mendes PF; Bahia MT
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242662
[TBL] [Abstract][Full Text] [Related]
2. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
[TBL] [Abstract][Full Text] [Related]
3. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
5. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
[TBL] [Abstract][Full Text] [Related]
6. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
7. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395
[TBL] [Abstract][Full Text] [Related]
8. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
11.
Santos CC; Lionel JR; Peres RB; Batista MM; da Silva PB; de Oliveira GM; da Silva CF; Batista DGJ; Souza SMO; Andrade CH; Neves BJ; Braga RC; Patrick DA; Bakunova SM; Tidwell RR; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203486
[TBL] [Abstract][Full Text] [Related]
12. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
[TBL] [Abstract][Full Text] [Related]
14. Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
Assíria Fontes Martins T; de Figueiredo Diniz L; Mazzeti AL; da Silva do Nascimento ÁF; Caldas S; Caldas IS; de Andrade IM; Ribeiro I; Bahia MT
PLoS One; 2015; 10(6):e0128707. PubMed ID: 26076455
[TBL] [Abstract][Full Text] [Related]
15. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
[TBL] [Abstract][Full Text] [Related]
16. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
17. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice.
Diniz LF; Mazzeti AL; Caldas IS; Ribeiro I; Bahia MT
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555633
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
[TBL] [Abstract][Full Text] [Related]
19. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
[TBL] [Abstract][Full Text] [Related]
20. Different Therapeutic Outcomes of Benznidazole and VNI Treatments in Different Genders in Mouse Experimental Models of Trypanosoma cruzi Infection.
Guedes-da-Silva FH; Batista DG; da Silva CF; Meuser MB; Simões-Silva MR; de Araújo JS; Ferreira CG; Moreira OC; Britto C; Lepesheva GI; Soeiro Mde N
Antimicrob Agents Chemother; 2015 Dec; 59(12):7564-70. PubMed ID: 26416857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
